Abstract
Ten obsessive-compulsive patients received single-blind treatment with fluvoxamine, a selective serotonin reuptake inhibitor, for several weeks following at least 2 weeks of placebo. The group showed significant improvement, as measured by several clinical scales and self-ratings; six patients were judged responders. Fluvoxamine appears effective in treating severe obsessive-compulsive disorder.
| Original language | English |
|---|---|
| Pages (from-to) | 1059-1061 |
| Number of pages | 3 |
| Journal | American Journal of Psychiatry |
| Volume | 144 |
| Issue number | 8 |
| DOIs | |
| State | Published - 1987 |
| Externally published | Yes |